These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Assessment of respiratory function in patients with chronic obstructive pulmonary diseases treated with budesonide].
    Author: Kozak-Szkopek E.
    Journal: Pneumonol Alergol Pol; 1995; 63(9-10):532-8. PubMed ID: 8620175.
    Abstract:
    The aim of the study was to carry out assessment of the respiratory function of patients with COPD undergoing a three month (600 microgram) treatment with an inhaled steroid--Budesonide. This was a double blind study carried out on 57 patients. During treatment with Budesonide a clinical improvement was seen. Respiratory function parameters did not alter throughout the 3 month treatment period, although bronchial reactivity diminished. Side effects were seen only in 3 patients--in all it was dysphonia. It seems that Budesonide can be added to other treatment protocols in patients with exacerbations of chronic bronchitis.
    [Abstract] [Full Text] [Related] [New Search]